HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sergey Filippov Selected Research

oxidized low density lipoprotein

11/2016Liver-specific ATP-citrate lyase inhibition by bempedoic acid decreases LDL-C and attenuates atherosclerosis.
8/2014LDL-cholesterol reduction in patients with hypercholesterolemia by modulation of adenosine triphosphate-citrate lyase and adenosine monophosphate-activated protein kinase.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sergey Filippov Research Topics

Disease

3Metabolic Syndrome (Dysmetabolic Syndrome X)
08/2013 - 12/2012
2Body Weight (Weight, Body)
08/2014 - 01/2013
2Obesity
08/2013 - 01/2013
2Dyslipidemias (Dyslipidemia)
08/2013 - 01/2013
1Lymphoma (Lymphomas)
10/2017
1Neoplasms (Cancer)
10/2017
1Myotoxicity
11/2016
1Atherosclerosis
11/2016
1Hypercholesterolemia
08/2014
1Myalgia
08/2014
1Inflammation (Inflammations)
08/2013
1Insulin Resistance
08/2013
1Hyperlipidemias (Hyperlipidemia)
01/2013
1Cardiovascular Diseases (Cardiovascular Disease)
01/2013
1Metabolic Diseases (Metabolic Disease)
12/2012
1Vascular Diseases (Vascular Disease)
09/2005
1Vascular Remodeling
09/2005
1Hyperplasia
09/2005
1Neointima
09/2005

Drug/Important Bio-Agent (IBA)

48- hydroxy- 2,2,14,14- tetramethylpentadecanedioic acidIBA
11/2016 - 01/2013
3LipidsIBA
08/2014 - 12/2012
2Pharmaceutical PreparationsIBA
10/2017 - 12/2012
2Adenosine Triphosphate (ATP)IBA
10/2017 - 08/2014
2oxidized low density lipoproteinIBA
11/2016 - 08/2014
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
11/2016 - 08/2014
2LDL CholesterolIBA
08/2014 - 08/2013
2Glucose (Dextrose)FDA LinkGeneric
08/2014 - 01/2013
2C-Reactive ProteinIBA
08/2014 - 08/2013
2Investigational DrugsIBA
08/2013 - 01/2013
1Member 1 Subfamily B ATP Binding Cassette TransporterIBA
10/2017
1PolymersIBA
10/2017
1Cytostatic AgentsIBA
10/2017
1Doxorubicin (Adriamycin)FDA LinkGeneric
10/2017
1Drug CarriersIBA
10/2017
1HydrazonesIBA
10/2017
1MicellesIBA
10/2017
1ProdrugsIBA
11/2016
1LDL Receptors (LDL Receptor)IBA
11/2016
1Acyl Coenzyme A (Acyl CoA)IBA
11/2016
1ATP Citrate (pro-S)-Lyase (Citrate Synthase, ATP)IBA
11/2016
1EnzymesIBA
08/2014
1Adenosine Monophosphate (AMP)IBA
08/2014
1citrate (pro-3S)-lyaseIBA
08/2014
1Protein Kinases (Protein Kinase)IBA
08/2014
1Biomarkers (Surrogate Marker)IBA
08/2013
1SterolsIBA
01/2013
1Lipoproteins (Lipoprotein)IBA
01/2013
1Fatty Acids (Saturated Fatty Acids)IBA
01/2013
1AMP-Activated Protein KinasesIBA
12/2012
1CollagenIBA
09/2005
1Matrix Metalloproteinase 14 (MT1-MMP)IBA
09/2005
1Peptide Hydrolases (Proteases)FDA Link
09/2005

Therapy/Procedure

1Therapeutics
11/2016
1Glycemic Control
01/2013